checkAd

    ADVR--Gib Aids keine schance - 500 Beiträge pro Seite

    eröffnet am 27.03.00 19:09:39 von
    neuester Beitrag 10.04.00 00:42:17 von
    Beiträge: 3
    ID: 104.774
    Aufrufe heute: 0
    Gesamt: 315
    Aktive User: 0


     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 27.03.00 19:09:39
      Beitrag Nr. 1 ()
      Hat jemand neueste Informationen über Erfolge in diesem
      Bereich?
      Was meint Ihr Dr. Hirschman schft was gegn Aids?
      Friday, March 24, 2000
      04:27 ET Capital Research Group: TheSubway.com Update on MonsterDaata.com (MT)

      Thursday, March 16, 2000
      09:17 ET Corporate Profile for Advanced Viral Research Corp. (BW)

      Tuesday, March 14, 2000
      12:49 ET TheSubway.com Announces Investment Opinion On Dicom Imaging Systems (IW)

      Monday, March 13, 2000
      07:58 ET TheSubway.com Announces Investment Opinion On Dicom Imaging Systems (IW)

      Wednesday, March 08, 2000
      07:01 ET Capital Research Group Inc. Announces Investment Opinion On Berens Industries (IW)

      05:00 ET Capital Research Group Announces Investment Opinion on Berens Industries (BW)

      Monday, February 28, 2000
      07:09 ET Capital Research Group Inc. Announces Investment Opinion on Dicom Imaging Systems, Imaging Tech., Ises Corporation and StereoScape.com (BW)

      Friday, February 18, 2000
      11:09 ET Advanced Viral Research Corp. Receives Approval in Argentina for Human Clinical Studies With Antiviral "Substance R" (BW)



      http://www.stockpoint.com/quote.asp?Symbol=ADVR&Mode=NEWS
      Avatar
      schrieb am 28.03.00 17:32:42
      Beitrag Nr. 2 ()
      Capital Research Group: TheSubway.com Announces Investment Opinion on Linux Wizardry
      ADVR


      RELATED QUOTES

      ADVR 0.69 -0.01
      CSCO 78 1/2 - 1 9/16
      MSFT 103 15/16 - 1/8
      IBM 126 1/8 - 3/4
      SUNW 103 5/8 - 1 3/8
      DELL 57 1/8 - 3/4
      INTC 140 5/16 - 2 3/8
      PHYX 20 7/8 - 1/8
      RNTK 3.31 0
      SDWSF 10 7/8 1/8
      VSRC 43 2
      LNXWF 3.66 0.16
      BBAN 4 1/8 -0.91
      VDOT 6 1/2 -0.16
      USVO 4 1/4 - 1/2
      ACUC 22 -1.81
      PFOO 4.60 0.35

      MAR 28, 2000, M2 Communications - Weston, Florida -- TheSubway.com Announces Investment Opinion on Linux Wizardry (OTCBB: LNXWF ) with a short term target price of $9.00 per share.

      Linux Wizardry Inc. (OTCBB: LNXWF ) just announced a $5 million financing.

      The capital will be used for the development and production of their Linux based low-cost router. LNXWF plans to release the beta version of the Linux Apprentice router in April of 2000 and release a commercial version of the Apprentice router by June of 2000

      The LinuxWizardry router will allow small to medium businesses to take control of their network for the first time because of the user friendly features that will not require an expensive network specialist to configure.

      The router business is presently dominated by Cisco Systems (NASDAQ: CSCO ) which supplies the current Microsoft (NASDAQ: MSFT ) Windows based system.

      Linux now powers 31% of all web servers, also IBM (NYSE: IBM ), Sun Microsystems, Inc. (NASDAQ: SUNW ), Dell Computers (NASDAQ: DELL ) and Intel (NASDAQ: INTC ) are embracing Linux; creating products to support the operating system and investing in Linux-based businesses.

      Most small businesses do not have and cannot afford to have a network specialist on staff to manage the network router. A network expert is very expensive and an unskilled amateur encounters great difficulty with the current generation of products. The LinuxWizardry router will allow these businesses to take control of their networks for the first time".

      LNXWF is currently trading around 3.50 per share. CRG feels the stock is a great buy. CRG is planning to initiate an intense public relations campaign to alert new, experienced investors of this opportunity. CRG feels that the stock could be trading over the $9.00+ range in the short term.



      OTCBB volume leaders?

      Physiometrix, Inc (OTCBB: PHYX ), Broadband Wireless Intl Cp (OTCBB: BBAN ), Rentech, Inc (OTCBB: RNTK ), Virtualsellers.com Inc (OTCBB: VDOT ), USA Video Inter (OTCBB: USVO ), All Comunications Corp (OTCBB: ACUC ), Advanced Viral Research (OTCBB: ADVR ), Sideware Systems Inc (OTCBB: SDWSF ), Planet 411.com Cp (OTCBB: PFOO ), Vsource Inc (OTCBB: VSRC )



      About TheSubway.com

      TheSubway.com, a wholly owned online asset of Capital Research Group, Inc. was developed solely for experienced, risk tolerant investors. Subscribers to TheSubway.com receive daily market commentary reports for select companies trading on various markets. Sophisticated investors are also able to receive for free, select, rare research reports and investor kits on up and coming emerging companies while they are still not widely known.



      About Capital Research Group Inc.

      Through TheSubway.com, Capital Research Group (CRG) introduces what in its opinion are undervalued companies to the investment community. Capital Research Group strives to locate companies with enormous growth potential.

      CRG is a full service public relations / Investor relations firm. For more information about our products or services, please contact CRG at 954-217-9555 or visit us at http://www.thesubway.com .

      All material herein was prepared by Capital Research Group Inc. (CRG) based upon information supplied by the company or other sources believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this report, have not approved the statements made in this report. This discussion contains forward-looking statements that involve risks and uncertainties. A company`s actual results could differ materially from those described in any forward-looking statements or announcements discussed within. This material is for information purposes only and should not be construed as an offer or solicitation of an offer to buy or sell the securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

      Please consult a broker before purchasing or selling any securities viewed on www.thesubway.com . CRG has been compensated by one or more of the companies listed herein (150,000 FPMCF) for the preparation and distribution of this report. CRG intends to sell its shares in the event the shares rise in value. CRG may sell its shares for less than the target price given in this opinion. CRG`s affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market."
      Avatar
      schrieb am 10.04.00 00:42:17
      Beitrag Nr. 3 ()
      Hallo zusammen...

      meint ihr, ADVR hat wieder Potential, dass es wieder wenigsten die
      alten Höchststände von $1,45 erreicht? Ich hoffe mal, es kommen bald
      News zu dem Aidsmittel...


      MfG Arne


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      ADVR--Gib Aids keine schance